HC Wainwright set a $7.00 target price on EDAP TMS S.A. (NASDAQ:EDAP) in a research note published on Wednesday, July 19th. The firm currently has a buy rating on the medical equipment provider’s stock.
Other analysts have also recently issued research reports about the stock. ValuEngine raised shares of EDAP TMS from a sell rating to a hold rating in a research note on Friday, May 19th. Zacks Investment Research raised shares of EDAP TMS from a strong sell rating to a hold rating in a research report on Thursday, May 18th.
Shares of EDAP TMS (EDAP) traded down 1.36% on Wednesday, reaching $2.91. The company’s stock had a trading volume of 6,250 shares. The company has a market cap of $84.38 million, a PE ratio of 17.64 and a beta of 0.98. The firm has a 50 day moving average of $3.31 and a 200 day moving average of $2.94. EDAP TMS has a 52-week low of $2.25 and a 52-week high of $3.85.
EDAP TMS (NASDAQ:EDAP) last issued its quarterly earnings data on Wednesday, May 17th. The medical equipment provider reported $0.13 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.16. EDAP TMS had a net margin of 11.95% and a return on equity of 27.90%. The company had revenue of $9.29 million for the quarter, compared to analysts’ expectations of $9.35 million. Analysts predict that EDAP TMS will post $0.18 earnings per share for the current year.
A hedge fund recently bought a new stake in EDAP TMS stock. Essex Investment Management Co. LLC acquired a new position in EDAP TMS S.A. (NASDAQ:EDAP) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 52,161 shares of the medical equipment provider’s stock, valued at approximately $172,000. Essex Investment Management Co. LLC owned about 0.18% of EDAP TMS at the end of the most recent reporting period. Institutional investors and hedge funds own 8.15% of the company’s stock.
About EDAP TMS
EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.
Receive News & Ratings for EDAP TMS S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EDAP TMS S.A. and related companies with MarketBeat.com's FREE daily email newsletter.
